Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.

Brian K Jefferson, Emmanouil S Brilakis, M Nicholas Burke, Yader Sandoval, Olga C Mastrodemos, Bavana V Rangan, Salman Allana, Korhan Soylu, Ufuk Yildirim, Nidal Abi Rafeh, William Nicholson, Wissam A Jaber, Stephane Rinfret, Mitul Patel, Taral Patel, Bahadir Simsek, Ahmed ElGuindy, Rhian Davies, Oleg Krestyaninov, Paul Poommipanit, Jaikirshan Khatri, Omer Goktekin, Sevket Gorgulu, Khaldoon Alaswad, Darshan Doshi, Hideki Koike, Judit Karacsonyi, Spyridon Kostantinis, Farouc A Jaffer

Journal: International journal of cardiology 2022;367():20-25

PMID: 35964847

Abstract

BACKGROUND

Preprocedural coronary computed tomography angiography (CCTA) can be useful in procedural planning for chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

METHODS

We examined the clinical, angiographic and procedural characteristics and outcomes of cases with vs. without preprocedural CCTA in PROGRESS-CTO (NCT02061436). Multivariable logistic regression was used to adjust for confounding factors.

RESULTS

Of 7034 CTO PCI cases, preprocedural CCTA was used in 375 (5.3%) with increasing frequency over time. Patients with preprocedural CCTA had a higher prevalence of prior coronary artery bypass graft surgery (39% vs. 27%, p < 0.001) and angiographically unfavorable characteristics including higher prevalence of proximal cap ambiguity (52% vs. 33%, p < 0.001) and moderate/severe calcification (59% vs. 41%, p < 0.001) compared with those without CCTA. CCTA helped resolve proximal cap ambiguity in 27%, identified significant calcium not seen on diagnostic angiography in 18%, changed estimated CTO length by >5 mm in 10%, and was performed as part of initial coronary artery disease work up in 19%. CCTA cases had higher J-CTO (2.6 ± 1.2 vs. 2.3 ± 1.3, p < 0.001) and PROGRESS-CTO (1.3 ± 1.0 vs. 1.2 ± 1.0 p = 0.027) scores. After adjusting for potential confounders, cases with preprocedural CCTA had similar technical success (odds ratio [OR]: 1.18, 95% confidence interval [CI], 0.83-1.67) and incidence of major adverse cardiovascular events (OR: 1.47, 95% CI, 0.72-3.00).

CONCLUSION

Preprocedural CCTA was used in ~5% of CTO PCI cases. While CCTA may help with procedural planning, especially in complex cases, technical success and MACE were similar with or without CCTA.

Copyright © 2022 Elsevier B.V. All rights reserved.

Address: Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.; Massachusetts General Hospital, Harvard University, Boston, MA, USA.; Division of Cardiology, Henry Ford Hospital, Detroit, MI, USA.; Department of Cardiology, Acibadem Kocaeli Hospital, Kocaeli, Turkey.; Bahcelievler Memorial Hospital, Istanbul, Turkey.; Cleveland Clinic Foundation, Cleveland, OH, USA.; University Hospitals, Case Western Reserve University, Cleveland, OH, USA.; Department of Invasive Cardiology, Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation, Novosibirsk, Russian Federation.; Wellspan York Hospital, York, PA, USA.; Aswan Heart Centre, Aswan, Egypt.; Tristar Hospitals, TN, USA.; UCSD Medical Center, Division of Cardiovascular Medicine, La Jolla, CA, USA.; Emory University, Atlanta, GA, USA.; North Oaks Medical Center, Hammond, LA, USA.; Department of Cardiology, Ondokuz Mayis University, Samsun, Turkey.; Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.